Looking to diversify beyond LABD? The ETFs below have historically moved differently from LABD, which may reduce portfolio volatility when combined in a suitable allocation. The stock ideas table highlights individual companies with the same low-correlation characteristics. Correlation can change and does not guarantee that one asset will rise when another falls.
Best Diversifiers for LABD
2236 ETFs have low correlation with LABD (below 0.3), 2132 of which are negatively correlated. The least correlated is SPDR S&P Biotech ETF (XBI) (Health & Biotech Equities) with a 1Y correlation of -1.00, roughly unchanged from -1.00 over 5 years.
How candidates are selected| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Category | Compare |
|---|---|---|---|---|---|---|---|
| SPDR S&P Biotech ETF | -1.00 | -1.00 | -1.00 | 94 | Health & Biotech Equities | LABD vs XBI | |
| Direxion Daily S&P Biotech Bull 3x Shares | -1.00 | -1.00 | -1.00 | 94 | Leveraged Equities | LABD vs LABU | |
| ALPS Medical Breakthroughs ETF | -0.95 | -0.94 | -0.95 | 95 | Health & Biotech Equities | LABD vs SBIO | |
| Virtus LifeSci Biotech Clinical Trials ETF | -0.93 | -0.92 | -0.94 | 96 | Health & Biotech Equities | LABD vs BBC | |
| ProShares Ultra Nasdaq Biotechnology | -0.91 | -0.92 | -0.91 | 89 | Leveraged Equities | LABD vs BIB |
To view more results, upgrade your current subscription plan.
Build a portfolio that complements LABD
Add LABD to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.
Analyze a portfolio with LABD